In the present study, we used qRT-PCR, TMA-IHC, and bioinformatic analyses to detect LTBP2 mRNA and protein expression levels in CRC and reveal the relationship between LTBP2 expression and the clinical features of CRC patients. This evidence concerns the gene LTBP2 and colorectal carcinoma.